Feigal successor Schultz brings insider perspective to FDA role
This article was originally published in Clinica
Executive Summary
Daniel Schultz has been named director of the FDA's Center for Devices and Radiological Health (CDRH), after serving as acting director of the centre since April 1. He replaces David Feigal, who resigned from the agency to take up a post in the private sector.